systemic lymphoma with concurrent CNS lymphoma
Showing 1 - 25 of >10,000
CNS Involvement in Primary Mediastinal Large B-Cell Lymphoma
Active, not recruiting
- Primary Mediastinal Large B-cell Lymphoma (PMBCL)
- DISEASE
- (no location specified)
May 4, 2023
CLIMB: CNS Lymphoma Imaging and Molecular Biomarkers Study
Not yet recruiting
- CNS Lymphoma
-
London, United KingdomThe Royal Marsden NHS Foundation Trust
Apr 12, 2023
Primary Mediastinal Large B-cell Lymphoma With CNS Involvement
Recruiting
- Primary Mediastinal Large B-cell Lymphoma (PMBCL)
-
Milan, ItalyOspedale San Raffaele
Aug 29, 2023
CNS Lymphoma, Primary CNS Lymphoma, Secondary CNS Lymphoma Trial in San Francisco (Tafasitamab, Lenalidomide)
Recruiting
- CNS Lymphoma
- +2 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Aug 10, 2022
Non-hodgkin Lymphoma, B Cell Trial in Switzerland (ctDNA detection)
Not yet recruiting
- Non-hodgkin Lymphoma, B Cell
- ctDNA detection
-
Aarau, Switzerland
- +12 more
Oct 18, 2023
Lymphoma Trial in Houston (Radiation Therapy, Dexamethasone, Etoposide phosphate)
Recruiting
- Lymphoma
- Radiation Therapy
- +5 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Dec 9, 2022
Primary CNS Lymphoma Trial in London (CD19CAR T-cells)
Recruiting
- Primary CNS Lymphoma
- CD19CAR T-cells
-
London, United KingdomUniversity College London Hospital
Jun 13, 2022
Diffuse Large B Cell Lymphoma, CNS Metastasis Trial in Herlev
Recruiting
- Diffuse Large B Cell Lymphoma
- Central Nervous System Metastasis
-
Herlev, Capital Region, DenmarkHerlev Hopital
Mar 21, 2022
Primary CNS Lymphoma, Secondary CNS Lymphoma, Relapsed Cancer Trial in Miami (drug, procedure, radiation)
Not yet recruiting
- Primary Central Nervous System Lymphoma
- +3 more
- Pemetrexed
- +3 more
-
Miami, FloridaMiami Cancer Institute at Baptist Health, Inc.
Dec 23, 2022
Primary CNS Lymphoma Trial in Paris (PET-MRI)
Not yet recruiting
- Primary Central Nervous System Lymphoma
-
Paris, FranceHôpital Pitié Salpêtrière
May 20, 2022
CNS Lymphoma Trial in Shanghai (Orelabrutinib, Rituximab, Chemotherapy)
Not yet recruiting
- CNS Lymphoma
- Orelabrutinib
- +2 more
-
Shanghai, Shanghai, ChinaRuijin Hospital, Shanghai Jiao Tong University School of Medicin
Jun 22, 2023
Classic Hodgkin Lymphoma Trial (Concurrent penpulimab and AVD, Sequential penpulimab and AVD)
Not yet recruiting
- Classic Hodgkin Lymphoma
- Concurrent penpulimab and AVD
- Sequential penpulimab and AVD
- (no location specified)
Jul 10, 2023
Primary CNS Lymphoma Trial in San Francisco (Hyperpolarized pyruvate (13C), Magnetic resonance imaging (MRI))
Recruiting
- Primary CNS Lymphoma
- Hyperpolarized pyruvate (13C)
- Magnetic resonance imaging (MRI)
-
San Francisco, CaliforniaUniversity of California, San Francisco
Apr 22, 2022
NK-T-Cell Lymphoma, Extranodal Trial in Shanghai (4 cycles of ESA regimen with sandwiched radiotherapy, 2 cycles of ESA regimen
Not yet recruiting
- NK-T-Cell Lymphoma, Extranodal
- 4 cycles of ESA regimen with sandwiched radiotherapy
- +2 more
-
Shanghai, Shanghai, ChinaRuijin Hospital
Sep 29, 2023
CNS Lymphoma, Secondary CNS Lymphoma Trial run by the National Cancer Institute (NCI) (TEDD-R, TEDDI-R, Ibrutinib)
Recruiting
- Central Nervous System Lymphoma
- Secondary Central Nervous System Lymphoma
- TEDD-R
- +5 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 23, 2023
Primary Vitreoretinal Lymphoma Trial in Beijing (Intravitreal injection of methotrexate)
Recruiting
- Primary Vitreoretinal Lymphoma
- Intravitreal injection of methotrexate
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Jul 11, 2023
Primary CNS Lymphoma Trial in Stuttgart (Venetoclax, Obinutuzumab)
Terminated
- Primary CNS Lymphoma
-
Stuttgart, Baden-Württemberg, GermanyKlinikum Stuttgart
Jan 18, 2022
CNS Lymphoma Trial in Aarhus (Immunochemo)
Completed
- Central Nervous System Lymphoma
-
Aarhus, DenmarkElisa Jacobsen Pulczynski
Aug 3, 2022
Primary Diffuse Large B-cell Lymphoma of the CNS (CNS), Aggressive B-cell Lymphoma With Secondary Involvement of the CNS Trial
Suspended
- Primary Diffuse Large B-cell Lymphoma of the Central Nervous System (CNS)
- Aggressive B-cell Lymphoma With Secondary Involvement of the CNS
- Obinutuzumab
- +5 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jul 6, 2022
